[1] Cornely O.A., Bassetti M., Calandra T., Garbino J., Kullberg B.J., Lortholary O., W Meersseman, Akova M., Arendrup M.C., Arikan-Akdagli S., Bille J., Castagnola E., Cuenca-Estrella M., Donnelly J.P., Groll A.H., Herbrecht R., Hope W.W., Jensen H.E., Lass-Flörl C., Petrikkos G., Richardson M.D., Roilides E., Verweij P.E., Viscoli C., Ullmann A.J.,
ESCMID Guideline for the Diagnosis and Management of Candida Diseases 2012: Nonneutropenic Adult Patients,
Clin. Microbiol. Infect.,
18: 19-37 (2012).
[3] Latg J-P., The Cell Wall: A Carbohydrate Armour for the Fungal Cell, Mol. Microbiol, 66: 279-290 (2007).
[12] Ugochukwu Ibeji C., Oguejiofo U., Chukwuma Chime C., Godfrey Akpomie K., Onyinye Anarado C.J., Abiola Odewole O., Grishina M., Potemkin V.,
Dehydroacetic Acid-Phenylhydrazone as a Potential Inhibitor for Wild-Type HIV-1 Protease: Structural, DFT, Molecular Dynamics, 3D QSAR and ADMET Characteristics, Iran. J. Chem. Chem. Eng. (IJCCE), 40: 215-230 (2021).
[16] Meanwell N.A., Wallace O.B., Fang H., Wang H., Deshpande M., Wang T., Yin Z., Zadjura L., Tweedie D.L., Yeola S., Zhao F., Ranadive S., Robinson BA., Gong Y.F., Wang H.G., Spicer T.P., Blair W.S., Shi P.Y., Colonno R.J., Lin P.F.
, Inhibitors of HIV-1 Attachment. Part 2: An Initial Survey of Indole Substitution Patterns. Bioorg. Med. Chem. Lett.,
19: 1977-1981 (2009).
[25] Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Mennucci B., Petersson G.A., Nakatsuji H., Caricato M., Li X., Hratchian H.P., Izmaylov A.F., Bloino J., Zheng G., Sonnenberg J.L., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Vreven T., Montgomery J.A., Peralta J.E., Ogliaro F., Bearpark M., Heyd J. J., Brothers E., Kudin K.N., Staroverov V.N., Kobayashi R., Normand J., Raghavachari K., Rendell A., Burant J.C., Iyengar S.S., Tomasi J., Cossi M., Rega N., Millam J.M., Klene M., Knox J.E., Cross J.B., Bakken V., Adamo C., Jaramillo J., Gomperts R., Stratmann R.E., Yazyev O., Austin A.J., Cammi R., Pomelli C., Ochterski J.W., Martin R.L., Morokuma K., Zakrzewski V.G., Voth G.A., Salvador P., Dannenberg J., Dapprich S., Daniels A.D., Farkas Ö., Foresman J.B., Ortiz J.V., Cioslowski J., Fox D.J.,
https://gaussian.com/glossary/g09,
Gaussian 09 (Gaussian, Inc., Wallingford CT, 2009).
[34] Stevanovi´c N-L., Aleksic I., Kljun J., Bogojevic S.S., Veselinovic A., Nikodinovic-Runic J., Turel I., Djuran M.I., Gliši´c B.Ð.,
Copper(II) and Zinc(II) Complexes with the Clinically Used Fluconazole: Comparison of Antifungal Activity and Therapeutic Potential.,
Pharmaceuticals,
14: 24-44 (2021).
[44] Andrejevi´c T.P., War zajtis B., Gliši´c B.D., Vojnovic S., Mojicevic M., Stevanovi´c N.L., Nikodinovic-Runic J., Rychlewska U., Djuran M. I.,
Zinc(II) Complexes with Aromatic Nitrogen-Containing Heterocycles as Antifungal Agents: Synergistic Activity with Clinically used Drug Nystatin,
J. Inorg. Biochem.,
208: 111089 (2020).
[45] de Azevedo França J.A., Granado R., de Macedo Silva S.T., Santos-Silva G.D., Scapin S., Borba-Santos L.P., Rozental S., de Souza W., Martins-Duarte E.S., Barrias E.,
Rodrigues J.C.F.,
Navarro M.,
Synthesis and Biological Activity of Novel Zinc-Itraconazole Complexes In Protozoan Parasites and Sporothrix spp, Antimicrob. Agents Chemother.,
64: e01980-19 (2020).